Although several innovative and repurposed drugs have been approved for the treatment of
COVID-19 during the last year, we still do not have evidence-based knowledge on the best …

… In this supplement, we describe the challenges facing successful immunization of
immunocompromised patients and discuss key approaches toward overcoming these barriers to …

… Of these categories, immunocompromised patients are most susceptible to complications
if they contract a new disease (eg COVID-19). Healthcare professionals have been subject to …

… This suggests potential overuse of antibiotics as the IDSA guidelines only recommend
antibiotics for abscesses in immunocompromised patients, abscesses that are difficult to drain, or …

… events in immunocompromised patients across … immunocompromised patients will improve
diagnostic, treatment, and prevention approaches and facilitate future research in this patient …

… well-being and minimize possible harms for an individual patient. Vaccines are potentially
lifesaving for immunocompromised patients and should be treated as such. All transplant …

… of metric tons of antibiotics we have used in patients and livestock over the past half century
[2]… , created enormous populations of increasingly immunocompromised hosts, who develop …

… Further, AMR is a major risk to vulnerable, immunocompromised patients, like those on
chemotherapy or immunosuppressants, taking away an essential line of defense and turning …

… SARS-CoV-2 for cancer patients may be similar to those of patients without cancer, considering
data extrapolation from other vaccines and the mechanism of action of most COVID-19 …

… patients. Barriers to the implementation of antimicrobial stewardship strategies in
immunocompromised … antimicrobial stewardship strategies in high-risk immunocompromised …